What We're Reading: Page 304
Industry reads hand-picked by our editors
May 19, 2017
May 18, 2017
-
The Wall Street Journal
As states wage battles on high drug prices, drugmakers fight back
-
Bloomberg
Pharma heir seeks a new Holy Grail as generic drugs run dry
-
Quartz
Syphilis is on the rise because penicillin isn’t profitable
-
The Washington Post
What Amazon could do to the business of selling prescription drugs
May 17, 2017
May 16, 2017
-
Bloomberg
Samsung looks beyond smartphones to next-gen biologics
-
Fortune
Why the companies that actually make your drugs are in a merger frenzy
-
The Seattle Times
Genoa Pharmaceuticals, led by biotech veteran Bruce Montgomery, raises $62M to fund clinical trials
-
The New York Times
When the immune system thwarts lifesaving drugs
May 15, 2017
-
Crain's Detroit Business
Life after Pfizer: A decade later, Michigan pharmaceutical companies have found paths to growth
-
The Boston Globe
Henri Termeer, key biotech leader who built Genzyme into an industry giant, dead at 71
-
Forbes
Pharma's not so stingy with R&D after all
-
Phys.org
Cutting-edge analysis reveals how different drugs interact with the same target
May 12, 2017
May 11, 2017
-
San Francisco Business Times
Gilead's last chronic HIV drug — and what it plans to do now
-
Xconomy
Stalled, or rising momentum? New York wrestles with its biotech future
-
Pharmaceutical Processing
Global pharma market roundtable: China vs. Ireland
-
The San Diego Union-Tribune
Mice with trouble eating, mating, reveal potential arthritis drug
Previous
